funded by Shenzhen Key Medical Discipline Construction Fund(No.SZXK015);Guangdong Provincial Key Clinical Specialty Construction Project,National Key Clinical Specialty Construction Project and Guangdong Medical Science and Technology Research Fund(No.A2021230).
Background:Cholangiocarcinoma(CCA)represents the epithelial cell cancer with high aggressiveness whose five-year survival rate is poor with standard treatment.Calcyclin-binding protein(CACYBP)shows aberrant expression...